Colgate surpasses estimates with strong Q1FY24 performance; stocks rise
Key drivers of this growth were the successful execution of its oral care category strategy, including the relaunch of its flagship product, CDC, with Arginine technology and early signs of recovery in rural markets Read More | Source: The Hindu Business Line